The recall of the prescription-only anxiety medication was initiated by its distributor, Viatris, on March 17 ...

The anxiety medication is being recalled due to "failed dissolution specifications." ...

If you take the prescription drug Xanax, you might want to consult your doctor before continuing to take it. A, Viatris, the manufacturer of Xanax, recalled 3-milligram extended-release tablets of ...

U.S. Food and Drug Administration issues a recall notice of an allotment of Xanax over dissolution failure.

A widely used anxiety medication is being pulled from shelves due to "failed dissolution specifications," the U.S. Food and Drug Administration (FDA) said. The agency's enforcement report said that ...

A specific batch of extended-release Xanax failed a key quality test.

A batch of Xanax XR has been recalled nationwide after the manufacturer found the drug may not release properly in the body. The FDA classified the issue as moderate risk.

WASHINGTON, D.C. — A nationwide recall has been issued for a specific lot of Xanax XR, a commonly prescribed anxiety medication, after federal regulators and the drug’s manufacturer flagged a ...

News of an anxiety medication recall has raised concern among patients, caregivers, and healthcare providers across the United States. For many people, medications used to manage anxiety are part of ...

The recall, issued March 17, affects lot number 8177156. The bottles contain 60 tablets of the 3-milligram extended-release version of the prescription drug, with an expiration da ...